Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020–2021

Emerging infectious diseases(2021)10.3201/eid2803.211993Source: DataRank Database

Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020–2021 is a research paper published in Emerging infectious diseases (2021). On theSindex it has a DataRank of 0. It has been cited 26 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access26 citations

Download PDF

Cite:

Linked data & code

gisaid

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (4 grants)Impact (FWCI 1.48)OA: goldTopics (57)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Priscila T. Rodrigues ORCID,Anderson R.J. Fernandes,Rodrigo M. Corder ORCID,Juliana Tonini ORCID,Lewis Buss ORCID

Live enrichment

PubMed:34963505 PMC:PMC8888227 OpenAlex:https://openalex.org/W4200048811

Medical Research Council

Grant: MR/S019510/1

Medical Research Council

Grant: MR/R015600/1

NIAID NIH HHS

Grant: U19 AI089681

National Institutes of Health

Grant: 5U19AI089681-11

Amazonian Center of Excellence in Malaria Research

FWCI

1.48

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

goldLicense: cc-by

journalhttps://wwwnc.cdc.gov/eid/article/28/3/pdfs/21-1993.pdf

publisherhttps://wwwnc.cdc.gov/eid/article/28/3/pdfs/21-1993.pdf

journalhttps://doi.org/10.3201/eid2803.211993

repositoryhttps://pubmed.ncbi.nlm.nih.gov/34963505

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/8888227

Fields of Study

SARS-CoV-2 and COVID-19 ResearchSARS-CoV-2 detection and testingCOVID-19 Clinical Research Studies0301 basic medicine03 medical and health sciences0303 health sciences

MeSH Terms

COVID-19SARS-CoV-2Antibodies, ViralBrazilChildHumans

Keywords

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)Coronavirus disease 2019 (COVID-19)Betacoronavirus2019-20 coronavirus outbreakAmazon rainforestCoronavirusEpidemiologyMedicineVirologySevere acute respiratory syndromeBiologyPathologyOutbreakDiseaseInfectious disease (medical specialty)VirusesBrazilZoonosesRespiratory InfectionsAmazonSeroprevalenceCovid-19Sars-cov-22019 Novel Coronavirus DiseaseSevere Acute Respiratory Syndrome Coronavirus 2Coronavirus DiseaseGamma VariantImmunologyInfectious and parasitic diseasesRC109-216Antibodies, ViralMicrobiologyAntibodies1117 Public Health and Health Services1108 Medical MicrobiologyHumansMANAUSViralChildScience & TechnologyRDispatch1103 Clinical SciencesInfectious DiseasesLife Sciences & Biomedicine

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being

Epidemiology of COVID-19 after Emergence of SARS-CoV-2 Gamma Variant, Brazilian Amazon, 2020–2021

FAIR Checklist

Authors (11)

Funding (4 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)